Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Sandoz Group Ag (0SAN) Share Price

Price 62.90 on 02-06-2026 at 18:15:01
Change 0.00 0%
Buy 0.00
Sell 0.00
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Unknown 112.00 at 62.90
Day's Volume: 544,503
Last Close: 62.90
Open: 0.00
ISIN: CH1243598427
Day's Range 0.00 - 0.00
52wk Range: 42.21198 - 72.42
Market Capitalisation: -
VWAP: 63.9819
Shares in Issue: 432.69m

Sector: Medicine and Biotech

Sandoz Group Ag (0SAN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 112 62.90 OTC Trade
 17:54:43 - 02-Jun-26
Unknown* 149 62.89906 OTC Trade
 17:54:36 - 02-Jun-26
Unknown* 273 63.10256 OTC Trade
 17:54:35 - 02-Jun-26
Unknown* 72 62.66903 OTC Trade
 17:54:30 - 02-Jun-26
Unknown* 87,988 62.90 OTC Trade
 17:50:26 - 02-Jun-26
Unknown* 11,880 62.90 OTC Trade
 17:50:26 - 02-Jun-26
Unknown* 9,202 62.88742 OTC Trade
 17:37:57 - 02-Jun-26
Unknown* 11,588 62.90 OTC Trade
 17:33:22 - 02-Jun-26
Unknown* 485 62.36474 OTC Trade
 17:20:05 - 02-Jun-26
Unknown* 913 62.80519 OTC Trade
 17:09:21 - 02-Jun-26
See more Sandoz Group Ag trades

Sandoz Group Ag (0SAN) Share Price History

Time period:
to
Date Open High Low Close Volume
1st Jun 2026 (Mon) 64.22 64.22 64.22 64.22 381,030
29th May 2026 (Fri) 65.60 65.60 65.60 65.60 248,176
28th May 2026 (Thu) 65.32 65.32 65.32 65.32 384,715
27th May 2026 (Wed) 64.52 64.52 64.52 64.52 83,780
26th May 2026 (Tue) 64.78 64.78 64.78 64.78 831,786
25th May 2026 (Mon) 64.44 64.44 64.44 64.44 0
22nd May 2026 (Fri) 64.44 64.44 64.44 64.44 540,595
21st May 2026 (Thu) 65.3675 65.3675 65.3675 65.3675 583,410
20th May 2026 (Wed) 65.88 65.88 65.88 65.88 1,140,055
19th May 2026 (Tue) 65.44669 65.44669 65.44669 65.44669 51,576
18th May 2026 (Mon) 65.00 65.00 65.00 65.00 37,166
15th May 2026 (Fri) 66.06007 66.06007 66.06007 66.06007 137,721
14th May 2026 (Thu) 67.95579 67.95579 67.95579 67.95579 0
13th May 2026 (Wed) 67.95579 67.95579 67.95579 67.95579 174,757
12th May 2026 (Tue) 67.21333 67.21333 67.21333 67.21333 312,259
11th May 2026 (Mon) 66.70893 66.70893 66.70893 66.70893 641,383
8th May 2026 (Fri) 66.99068 66.99068 66.99068 66.99068 97,586
7th May 2026 (Thu) 67.12 67.12 67.12 67.12 45,698
6th May 2026 (Wed) 67.16 67.16 67.16 67.16 288,719
5th May 2026 (Tue) 64.85216 64.85216 64.85216 64.85216 144,578
4th May 2026 (Mon) 62.21938 62.21938 62.21938 62.21938 0
See more Sandoz Group Ag price history

Sandoz Group Ag (0SAN) Regulatory News

Date Source Headline
12th Aug 2025 6:00 am GNW Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations
7th Aug 2025 6:00 am GNW Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter
30th Jul 2025 6:15 am GNW Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France
1st Jul 2025 1:56 pm GNW Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach
2nd Jun 2025 6:00 am GNW Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
21st May 2025 4:30 pm GNW Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars
30th Apr 2025 6:00 am GNW Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed
29th Apr 2025 4:00 pm GNW Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications
15th Apr 2025 12:50 pm GNW Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG
14th Apr 2025 3:00 pm GNW [Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US
See more Sandoz Group Ag regulatory news
FTSE 100 Latest
Value10,373.51
Change34.56

Login to your account

Forgot Password?

Not Registered